In the nucleus, MJ may interact with cell cycle regulatory proteins (cyclins, CDKs, and survivin) inducing cell cycle arrest at different phases in different cancer cell types (Table 1), thus inhibiting cell cancer growth, proliferation, and invasion. The gene discussed is BIRC5; the disease is cancer.